High-purity Hexarelin is essential for achieving reproducible experimental outcomes in laboratory models of pituitary secretion and receptor binding. Examining a third-party Certificate of Analysis (COA) ensures that experimental samples satisfy strict analytical benchmarks for chemical identity, chromatographic purity, and freedom from biological contaminants.
High-purity Hexarelin is essential for achieving reproducible experimental outcomes in laboratory models of pituitary secretion and receptor binding. Examining a third-party Certificate of Analysis (COA) ensures that experimental samples satisfy strict analytical benchmarks for chemical identity, chromatographic purity, and freedom from biological contaminants.
A Hexarelin Certificate of Analysis is an official, lot-specific analytical document issued by an independent laboratory verifying the identity, purity, quantity, and safety profile of the synthetic hexapeptide Hexarelin. It provides quantitative data from reverse-phase high-performance liquid chromatography (RP-HPLC), electrospray ionization mass spectrometry (ESI-MS), and bacterial endotoxin testing.
For research personnel conducting quantitative assays, relying on unverified reagents introduces significant confounding variables. A comprehensive COA acts as a document of quality assurance, certifying that the target compound matches its chemical structure without interference from synthesis side products, residual solvents, or heavy metals. When acquiring compounds from PX1 Research, every batch of Hexarelin 2mg is accompanied by a transparent, lot-traceable COA performed by accredited third-party testing facilities.
Hexarelin (His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2) is a synthetic growth-hormone secretagogue hexapeptide belonging to the ghrelin receptor agonist class. Structurally derived from GHRP-6, Hexarelin incorporates specific amino acid substitutions—notably D-2-methyl-tryptophan—which enhance its metabolic stability against enzymatic degradation in vitro.
In preclinical literature, Hexarelin is studied primarily for its robust ghrelin-receptor (GHSR-1a) activation and growth-hormone secretagogue activity in isolated pituitary cell cultures and rodent models. Research demonstrates that Hexarelin binds to both central ghrelin receptors and peripheral CD36 scavenger receptors, making it a valuable tool in cardiovascular and somatotropinergic research. Scientists interested in broader comparative signaling mechanisms can explore our comprehensive research library for detailed literature reviews.
A rigorous Hexarelin COA must detail multiple independent analytical modalities to confirm peptide integrity. The baseline assessment begins with physical appearance and solubility, ensuring the lyophilized cake is uniform and clear upon reconstitution in designated laboratory solvents.
The primary quantitative metric on any COA is chemical purity determined by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC). RP-HPLC separates the main peptide peak from synthetic impurities, deletion sequences, and oxidation products. In tandem, Mass Spectrometry (MS) confirms molecular weight, while limulus amebocyte lysate (LAL) assays quantify bacterial endotoxins. Researchers evaluating various growth-hormone secretagogues across our all peptides catalog can inspect individual COAs to verify these analytical standards.
During RP-HPLC analysis, the Hexarelin sample is passed through a hydrophobic stationary phase column under high pressure, eluted using an organic gradient (typically acetonitrile with 0.1% trifluoroacetic acid). UV detection at 214 nm or 220 nm records optical density over time, generating a chromatogram.
Purity is reported as the peak area percentage of the primary target signal relative to the total area of all integrated peaks. High-grade research reagents must exhibit a primary peak corresponding to ≥98.0% purity. Minor secondary peaks represent trace truncated sequences formed during solid-phase peptide synthesis (SPPS). A clean baseline and sharp single peak confirm that non-target peptides will not interfere with receptor binding assays or cell culture systems.
While HPLC measures purity, it cannot independently verify that the purified molecule is indeed Hexarelin. Mass spectrometry provides structural confirmation by measuring the mass-to-charge ratio (m/z) of the ionized peptide molecule.
Hexarelin has an exact monoisotopic molecular mass of approximately 887.04 Da (chemical formula C47H58N12O6). Electrospray Ionization Mass Spectrometry (ESI-MS) typically displays a prominent single-charged protonated ion peak [M+H]+ at ~888.0 m/z, or a double-charged species [M+2H]2+ at ~444.5 m/z. Verification that the observed mass aligns with theoretical values within ±0.5 Da guarantees correct sequence assembly.
Bacterial endotoxins—lipopolysaccharides (LPS) derived from Gram-negative bacterial outer membranes—pose severe risks to in vitro assays and cell viability. High endotoxin contamination can trigger non-specific inflammatory signaling pathways, altering gene expression and masking true experimental outcomes.
A valid Hexarelin COA must document endotoxin quantification using the kinetic chromogenic LAL method compliant with USP <85> guidelines. PX1 Research enforces strict limits, certifying that peptide lots contain <0.01 EU/mg of endotoxin. Additionally, elemental analysis and residual solvent testing ensure that reagents remain free from harmful heavy metals and synthetic reagents like piperidine or dimethylformamide (DMF).
When designing preclinical experiments, researchers frequently compare Hexarelin to other synthetic secretagogues within the growth hormone-releasing peptide class. Structural modifications across these peptides alter binding affinity, receptor selectivity, and signaling kinetics.
Compared to Ipamorelin 5mg, which demonstrates high selectivity for the GHSR-1a receptor without stimulating cortisol or prolactin release in animal models, Hexarelin exhibits significantly stronger peak GH release but may recruit secondary signaling cascades. Meanwhile, GHRP-2 5mg and GHRP-6 5mg offer intermediate potencies and distinct ghrelin-mimetic profiles. Reviewing comparative data in our Ipamorelin vs GHRP-2 vs Hexarelin guide allows investigators to select the appropriate control and test reagents for specific laboratory endpoints.
Maintaining chemical integrity from receipt to assay execution requires adherence to proper storage protocols. Lyophilized Hexarelin should be stored at -20°C or -80°C in a desiccated environment, shielded from light exposure to prevent tryptophan photo-oxidation.
For laboratory preparation, lyophilized vials should be brought to room temperature prior to reconstitution to minimize condensation. Reconstitution using sterile bacteriostatic water or phosphate-buffered saline (PBS) should be conducted under a laminar flow hood. Avoid vigorous vortexing, as mechanical shear stress can promote peptide aggregation. Detailed handling steps can be found in our dedicated Hexarelin reconstitution guide.
PX1 Research maintains a rigorous quality management system designed specifically to serve academic institutions, biotechnology firms, and contract research organizations. Every lot of peptide produced undergoes comprehensive analytical verification at an independent, ISO 17025 accredited laboratory prior to release.
Our synthetic processes utilize state-of-the-art solid-phase synthesis within GMP-compliant domestic facilities. All orders ship directly from centralized fulfillment centers in California and Arizona with same-day shipping for orders placed Monday through Friday. By maintaining complete lot traceability and providing downloadable COAs for every item, PX1 Research eliminates supply chain uncertainties for laboratory buyers.
For high-throughput screening, longitudinal animal studies, or multi-center research projects, consistent lot-to-lot purity is critical to maintaining experimental control. Minor variations in peptide purity across different batches can introduce statistically significant noise into research datasets.
PX1 Research supports institutional procurement through dedicated wholesale lab accounts. Institutional partners benefit from custom batch reservations, reserved lot testing, and direct access to raw chromatogram datasets for institutional compliance review.
What information is included on a Hexarelin Certificate of Analysis?
A standard Hexarelin COA includes lot numbers, manufacture date, sequence verification, physical appearance, mass spectrometry identity (ESI-MS), RP-HPLC purity percentage, net peptide content, and bacterial endotoxin levels (LAL assay).
What HPLC purity percentage is required for research-grade Hexarelin?
Analytical and preclinical research typically requires Hexarelin purity levels of ≥98.0% as determined by RP-HPLC to ensure trace synthetic impurities do not confound experimental results.
How is the identity of Hexarelin confirmed on a COA?
Identity is confirmed via mass spectrometry (ESI-MS or MALDI-TOF), which verifies the experimental mass matches Hexarelin's theoretical molecular weight (~887.04 Da).
Why is endotoxin testing necessary for Hexarelin research samples?
Endotoxins cause unwanted inflammatory responses in cell culture models and animal assays, masking specific receptor signaling. Testing ensures endotoxin levels remain below strictly controlled limits (<0.01 EU/mg).
How should lyophilized Hexarelin be stored upon delivery?
Lyophilized Hexarelin should be stored at -20°C or -80°C in a dry, dark place. Upon reconstitution, liquid aliquots should be kept at -20°C to prevent hydrolysis and enzymatic breakdown.
Does PX1 Research provide third-party COAs for every batch?
Yes, PX1 Research subjects every batch to independent ISO 17025 accredited laboratory testing, providing fully transparent, lot-specific COAs for all research compounds.
What solvent is recommended for reconstituting Hexarelin for laboratory assays?
Reconstitution is typically performed using sterile bacteriostatic water, sterile 0.9% saline, or laboratory-grade PBS depending on the specific in vitro or in vivo experimental protocol.
Can Hexarelin COAs be used for clinical or human diagnostic purposes?
No. PX1 Research compounds and their associated COA documentation are strictly intended for laboratory research use only and are not certified for human or clinical applications.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.